PLEASANTON, Calif. - Californer -- Relecura Inc., a leading provider of AI-powered patent and scientific innovation research, today announced that Coronavirus researchers across the globe who are working on discovering a solution to the crisis will have free access to its premium research platform until May 31, 2020. Using Relecura's premium research platform, researchers can find and build on existing IP and patent research that will aid them in finding solutions to the current COVID-19 world pandemic.
Interested researchers are invited to take advantage of this unique opportunity by emailing their name, title, work email and company name to researcher@relecura.com.
"The solution to the current crisis we're facing lies in the hands of researchers. Giving them access to the vast amount of existing technical knowledge that is available and the tools to process it to gain greater insight is our way of helping them help us," said George Koomullil, founder of Relecura Inc. "It's also a small way for us to demonstrate our thanks."
Relecura has published two research reports on Coronavirus to assist the research community. The first report, titled Coronavirus Patent Landscape, studies patents related to Coronavirus remedies and provides insights into patent data ranging from antigens and chemotherapeutics to gene therapy and supportive medication. On the other hand, Technical Exploration on Coronavirus explores topics related to Coronaviruses using the technical search engine Tech Explorer.
More on The Californer
About Relecura:
Relecura Inc is a software product company based in the San Francisco Bay Area. It's subsidiary, Relecura Technologies Pvt. Ltd., is in Bangalore. The company's full-stack cognitive cloud platform aids in managing strategic decisions by drawing powerful insights from patents and scientific literature using artificial intelligence, machine learning and natural language processing. Relecura's enterprise platform integrates the discovery and analysis of public documents with internal company documents, and thus builds a single knowledge base for organization-wide usage. Relecura has an API to help create custom tools for IP and business intelligence. For more details visit www.relecura.com.
Interested researchers are invited to take advantage of this unique opportunity by emailing their name, title, work email and company name to researcher@relecura.com.
"The solution to the current crisis we're facing lies in the hands of researchers. Giving them access to the vast amount of existing technical knowledge that is available and the tools to process it to gain greater insight is our way of helping them help us," said George Koomullil, founder of Relecura Inc. "It's also a small way for us to demonstrate our thanks."
Relecura has published two research reports on Coronavirus to assist the research community. The first report, titled Coronavirus Patent Landscape, studies patents related to Coronavirus remedies and provides insights into patent data ranging from antigens and chemotherapeutics to gene therapy and supportive medication. On the other hand, Technical Exploration on Coronavirus explores topics related to Coronaviruses using the technical search engine Tech Explorer.
More on The Californer
- Video Release: In Sunnyvale, Governor Newsom and Mayor Liccardo Tour Bloom Energy, Which is Refurbishing Ventilators for Use in California Hospitals During COVID-19 Outbreak
- Progressive Real Estate Partners Sells Former Acapulco Restaurant Building in Montclair, CA
- Former Isley Brother CHRIS JASPER pays tribute to a SAM COOKE classic ..."Nothing Can Change This Love"... Just Released!
- Brushwood Media Group In Association with Lynn TV Productions Presents "THE KRISTINA LYNN SHOW"
- Jim Campbell Beams Prayer Flags in a Message of Hope and Healing Atop San Francisco's Tallest Building
About Relecura:
Relecura Inc is a software product company based in the San Francisco Bay Area. It's subsidiary, Relecura Technologies Pvt. Ltd., is in Bangalore. The company's full-stack cognitive cloud platform aids in managing strategic decisions by drawing powerful insights from patents and scientific literature using artificial intelligence, machine learning and natural language processing. Relecura's enterprise platform integrates the discovery and analysis of public documents with internal company documents, and thus builds a single knowledge base for organization-wide usage. Relecura has an API to help create custom tools for IP and business intelligence. For more details visit www.relecura.com.
Source: Relecura Inc
0 Comments
Latest on The Californer
- Somatic Spiritual Counseling: New Psychotherapy Practice in Boulder, CO + Online
- San Francisco to Open New Shelter at Moscone Center in Response to COVID-19 and Need for More Social Distance in Shelters
- Long Beach Police Officer Tests Positive for COVID-19
- Long Beach: USNS Mercy Hospital Ship Arrives
- PSXDigital Offers Free Online Courses to All plus Defers Billing of Current Dealer Partners
- Airforwarders Association applauds passage of CARES Act
- California: Governor Newsom Takes Executive Action to Establish a Statewide Moratorium on Evictions
- San Francisco: Mayor London Breed and Community Leaders Stress Need for San Franciscans to Stay Home During the COVID-19 Outbreak
- Ventura College Foundation Marketplace Closed Until Further Notice
- San Jose: Public Review NOP: City National Civic Auditorium Loading Project
- New AUA/CSU Agreement Creates Admissions Pathway for African-American Medical Students
- San Francisco: Mayor Breed Announces Three New Drive-Thru/Drop-In COVID-19 Testing Sites for the Public and Additional Prioritized Testing for First Responders and Health Care Workers
- Connected Women of Influence Announces Immediate Access for all members to Network Online
- California: Governor Newsom Statement on Federal Supplemental Stimulus Bill
- San Jose: FLASH REPORT #34 - COVID-19 Mitigation and Response
- San Jose: Public Review Draft EIR for Avenues: The World Schools Project
- Generis Donate CARA Platform to Ventilator Manufacturers
- New Study Confirms Stratum Nutrition's NEM® Fast Efficacy in Pain & Stiffness Treatment After Only 10 Days
- Colorado Sustainable Apparel Brand Kastlfel Retools To Raise Funds For Colorado Covid Relief Fund
- Genstar Capital in Partnership with Management Announce Formation of Obsidian